Evidence map›Paper›PMID 31214168›Full record

ArticleFrontiers in immunology2019

Bone Marrow Plasma Cells Modulate Local Myeloid-Lineage Differentiation via IL-10.

Lingzhang Meng, Larissa Nogueira Almeida, Ann-Katrin Clauder, Timo Lindemann, Julia Luther, Christopher Link, Katharina Hofmann, Upasana Kulkarni, David Ming Wong, Jean-Pierre David and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Engineering nanoparticle therapeutics for food allergy.The Journal of allergy and clinical immunology · 2024
    Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Lingzhang MengInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Larissa Nogueira AlmeidaInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Ann-Katrin ClauderInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Timo LindemannInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Julia LutherDepartment of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Christopher LinkInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Katharina HofmannInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Upasana KulkarniDepartment of Internal Medicine, University of Michigan, Ann Arbor, MI, United States.
David Ming WongInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
Jean-Pierre DavidDepartment of Osteology and Biomechanics, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Rudolf Armin ManzInstitute for Systemic Inflammation Research, University of Lübeck, Lübeck, Germany.
University of Lübeck · DEUniversität Hamburg · DEUniversity Medical Center Hamburg-Eppendorf · DEUniversity of Michigan–Ann Arbor · USUniversity of Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bone marrow plasma cells have been reported to represent a major source of IL-10; however, the impact of plasma cell derived IL-10 in that tissue remains poorly understood. We confirm in this study that even in the absence of acute immune reactions, mature plasma cells represent the dominant IL-10+ cell population in the bone marrow, and identify myeloid-lineage cells as a main local target for plasma cell derived IL-10. Using Vert-X IL-10 transcriptional reporter mice, we found that more than 50% of all IL-10+ cells in bone marrow were CD138+ plasma cells, while other IL-10+ B lineage cells were nearly absent in this organ. Accordingly, IL-10 was found in the supernatants of short-term cultures of FACS-sorted bone marrow plasma cells, confirming IL-10 secretion from these cells. IL-10+ bone marrow plasma cells showed a B220-/CD19-/MHCII low phenotype suggesting that these cells represent a mature differentiation stage. Approximately 5% of bone marrow leucocytes expressed the IL-10 receptor (IL-10R), most of them being CD115+/Ly6C+/CD11c- monocytes. Compared to littermate controls, young B lineage specific IL-10 KO mice showed increased numbers of CD115+ cells but normal populations of other myeloid cell types in bone marrow. However, at 7 months of age B lineage specific IL-10 KO mice exhibited increased populations of CD115+ myeloid and CD11c+ dendritic cells (DCs), and showed reduced F4/80 expression in this tissue; hence, indicating that bone marrow plasma cells modulate the differentiation of local myeloid lineage cells via IL-10, and that this effect increases with age. The effects of B cell/plasma cell derived IL-10 on the differentiation of CD115+, CD11c+, and F4/80+ myeloid cells were confirmed in co-culture experiments. Together, these data support the idea that IL-10 production is not limited to early plasma cell stages in peripheral tissues but is also an important feature of mature plasma cells in the bone marrow. Moreover, we provide evidence that already under homeostatic conditions in the absence of acute immune reactions, bone marrow plasma cells represent a non-redundant source for IL-10 that modulates local myeloid lineage differentiation. This is particularly relevant in older individuals.

Indexed as

AnimalsAntigens, CD19B-LymphocytesBone Marrow CellsCell DifferentiationCell LineageCells, CulturedDendritic CellsHematopoiesisInterleukin-10MiceMice, KnockoutMice, TransgenicMyeloid CellsPlasma CellsAntigens, CD19Interleukin-10agingB cellsIL-10monocytesplasma cells

Identifiers

PMID31214168
PMCPMC6555095
OpenAlexW2947744017

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.